Clinical trial Recruiting at 1 site Observational Ages 40 and up

ShuntCheck performance in people with normal pressure hydrocephalus

Official title: Assessment of ShuntCheck Performance Characteristics in Asymptomatic Patients With Normal Pressure Hydrocephalus

Run by University of South Florida · NCT04011566 · Data updated 2026-11-12

This study tests whether the ShuntCheck test can reliably show flow or no flow in a ventriculoperitoneal shunt in adults with asymptomatic normal pressure hydrocephalus.

Quick facts

Study typeObservational
Ages40 Years and up
SexAll
Enrollment50 (estimated)
SponsorUniversity of South Florida
Academic / other
Locations1 site (Tampa, Florida)
StatusRecruiting
StartedJune 11, 2019
Main results expectedNovember 2026
Study endsNovember 2026
Registry record updatedMay 19, 2026
Trial IDNCT04011566 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 40 years or older with a ventriculoperitoneal shunt placed for normal pressure hydrocephalus who are visiting for routine care and can provide informed consent.

Probably not a fit

Patients with shunt conditions not represented by the test or in whom testing could interfere with care may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the performance characteristics of the ShuntCheck test in detecting flow status of a ventriculoperitoneal shunt among asymptomatic adults 40 and older who are receiving routine care for normal pressure hydrocephalus. Participants have a VP shunt and are evaluated during standard clinic visits; the test results are compared with the shunt’s usual management context. The study is conducted at the University of South Florida with NeuroDx Development as a collaborator. It seeks to determine how accurately ShuntCheck identifies flow versus no flow without altering standard patient care. No treatment or intervention beyond the ShuntCheck test is involved.

Why it matters

Potential benefit: If successful, ShuntCheck could help clinicians quickly assess shunt status during routine visits.

How similar studies have gone: Prior similar approaches have shown promise in evaluating shunt function, but this study applies ShuntCheck in asymptomatic normal pressure hydrocephalus, representing a relatively novel application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Asymptomatic men or women 40 years old or older and have a ventriculoperitoneal shunt placed for normal pressure hydrocephalus and are visiting for routine care.
* Capable of providing valid signed informed consent, or has a legal guardian, health care agent, or surrogate decision maker capable of providing valid, signed informed consent.

Exclusion Criteria:

* Presence of multiple shunts, or presence of more than one distal shunt catheter (regardless of function) crossing the clavicle ipsilateral to the shunt with suspected obstruction;
* ShuntCheck test would interfere with standard patient care, or emergency shunt surgery that cannot be delayed is indicated;
* Presence of an interfering open wound or edema over any portion of the ventriculoperitoneal shunt.

Where it's running

  • University of South Florida Department of Neurological Surgery and Brain Repair
    Tampa, Florida, United States
    Recruiting

Study contacts

  • Principal investigator: Naomi Abel, MD — University of South Florida
  • Study coordinator: Naomi Abel, MD
  • Email: nabel@usf.edu
  • Phone: 813 259-0904

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.